Finance

Minerva Neurosciences Hits An All Time High After A Positive Deve

Minerva Neurosciences Inc. (NASDAQ: NERV) shares soared as much as 40% and hit a new high of $10 after the company announced that the resultsMonday from a Primomed non-human primate study, which showed that treatment with an analog of MIN-301, the company’s investigational neuregulin-1 compound, has resulted in improvements in a range of symptoms associated with…

Gappy New Year, Part 3

In part 1 we noted the gaps to start 2015 that were likely to fill, and in part 2 we updated the progress.  Part 3 will close the series because there are no more gaps.  All are filled and now the market’s job is to prove it can use this process as support.  Lower lows…

2014 Hedged Portfolio Performance

During 2014 all of our portfolios lagged the market. Most of them by a significant margin. You’d think this would concern me, but it doesn’t. The purpose of a hedge is to position a portfolio for more than one outcome when market conditions are uncertain.This means a hedged portfolio will not track the market…by design….

What 2000, 2008 And 2015 May Have In Common

‘As a dog returns to its vomit, so the fool repeats their folly.’ – Proverbs 26:11 And about every seven or eight years it seems, in the modern economic discipline of bubblenometry. What hath the Fed wrought, and the crony accomplices to Wall Street in the Administration and Congress? Back to the brink, again.  Crouching…